NASDAQ:SWAV ShockWave Medical - SWAV Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding ShockWave Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $187.84 -0.09 (-0.05%) (As of 02/1/2023 12:29 PM ET) Add Compare Share Share Today's Range$186.37▼$192.3550-Day Range$175.41▼$264.2752-Week Range$113.36▼$320.54Volume108,519 shsAverage Volume454,177 shsMarket Capitalization$6.79 billionP/E Ratio80.62Dividend YieldN/APrice Target$244.44 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability ShockWave Medical MarketRank™ ForecastAnalyst RatingModerate Buy2.56 Rating ScoreUpside/Downside30.1% Upside$244.44 Price TargetShort InterestHealthy3.29% of Shares Sold ShortDividend StrengthN/ASustainability-0.55Upright™ Environmental ScoreNews Sentiment0.42Based on 15 Articles This WeekInsider TradingSelling Shares$13.88 M Sold Last QuarterProj. Earnings Growth24.66%From $2.96 to $3.69 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.3.07 out of 5 starsMedical Sector13th out of 1,053 stocksSurgical & Medical Instruments Industry1st out of 105 stocks 3.3 Analyst's Opinion Consensus RatingShockWave Medical has received a consensus rating of Buy. The company's average rating score is 2.56, and is based on 6 buy ratings, 2 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $244.44, ShockWave Medical has a forecasted upside of 30.1% from its current price of $187.84.Amount of Analyst CoverageShockWave Medical has only been the subject of 4 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted3.29% of the outstanding shares of ShockWave Medical have been sold short.Short Interest Ratio / Days to CoverShockWave Medical has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in ShockWave Medical has recently decreased by 9.16%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldShockWave Medical does not currently pay a dividend.Dividend GrowthShockWave Medical does not have a long track record of dividend growth. Previous Next 4.6 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreShockWave Medical has received a 72.86% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Diagnostic and treatment machines" and "Medical devices engineering" products. See details.Environmental SustainabilityThe Environmental Impact score for ShockWave Medical is -0.55. Previous Next 2.5 News and Social Media Coverage News SentimentShockWave Medical has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 15 news articles for ShockWave Medical this week, compared to 4 articles on an average week.Search Interest22 people have searched for SWAV on MarketBeat in the last 30 days. This is an increase of 144% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added ShockWave Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -56% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, ShockWave Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $13,881,584.00 in company stock.Percentage Held by InsidersOnly 3.90% of the stock of ShockWave Medical is held by insiders.Percentage Held by Institutions90.56% of the stock of ShockWave Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for ShockWave Medical are expected to grow by 24.66% in the coming year, from $2.96 to $3.69 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of ShockWave Medical is 80.62, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 132.70.Price to Earnings Ratio vs. SectorThe P/E ratio of ShockWave Medical is 80.62, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 109.22.Price to Book Value per Share RatioShockWave Medical has a P/B Ratio of 27.42. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About ShockWave Medical (NASDAQ:SWAV) StockShockwave Medical, Inc. operates as a medical device company, which focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease, C2 catheters for treating coronary artery disease, and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA.Read More Receive SWAV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ShockWave Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address SWAV Stock News HeadlinesJanuary 26, 2023 | marketbeat.comMergers and Acquisitions in 2023 Off To A Strong Start (SWAV)Mergers and acquisitions are common, especially across the health sector. Here are some lesser-known buyouts and how they could fare down the road.January 31, 2023 | finance.yahoo.comUpdated SCAI Guidance Includes Coronary IVL as a Treatment Option in All U.S. Catheterization Labs Regardless of Surgical Backup StatusFebruary 1, 2023 | PressReach (Ad)Top Innovation StockToday's stock market report features an AI Robotics tech stock with a $4 million order backlog.January 30, 2023 | finance.yahoo.comDoes ShockWave Medical (SWAV) Have an Expansion Potential?January 29, 2023 | americanbankingnews.comShockWave Medical (NASDAQ:SWAV) Shares Down 3.7% on Insider SellingJanuary 28, 2023 | americanbankingnews.comIsaac Zacharias Sells 4,000 Shares of ShockWave Medical, Inc. (NASDAQ:SWAV) StockJanuary 27, 2023 | americanbankingnews.comShockWave Medical (NASDAQ:SWAV) Given New $280.00 Price Target at Piper SandlerJanuary 26, 2023 | americanbankingnews.comInsider Selling: ShockWave Medical, Inc. (NASDAQ:SWAV) Director Sells $528,870.00 in StockFebruary 1, 2023 | PressReach (Ad)Top Innovation StockToday's stock market report features an AI Robotics tech stock with a $4 million order backlog.January 25, 2023 | americanbankingnews.comInsider Selling: ShockWave Medical, Inc. (NASDAQ:SWAV) CFO Sells $195,195.00 in StockJanuary 24, 2023 | americanbankingnews.comFY2022 EPS Estimates for ShockWave Medical, Inc. (NASDAQ:SWAV) Reduced by AnalystJanuary 22, 2023 | americanbankingnews.comQ4 2022 EPS Estimates for ShockWave Medical, Inc. (NASDAQ:SWAV) Reduced by AnalystJanuary 18, 2023 | marketwatch.comShockwave Medical Down 7% After Neovasc AcquisitionJanuary 18, 2023 | msn.comShockWave defended at BofA; says Neovasc “ not a big risk”January 17, 2023 | proactiveinvestors.comNeovasc stock soars on takeover deal plus more daily small cap moversJanuary 17, 2023 | finance.yahoo.comCan Shockwave Medical (SWAV) Keep the Earnings Surprise Streak Alive?January 17, 2023 | benzinga.comWhy Neovasc Shares Are Trading Higher TodayJanuary 17, 2023 | msn.comNeovasc soars ~30% as Shockwave set to acquire it in ~$100M dealJanuary 12, 2023 | finance.yahoo.comHow Doug Godshall Ignited The Spark At ShockwaveJanuary 5, 2023 | finance.yahoo.comAmedisys (AMED) Faces Macro Challenges, Margin PressureJanuary 4, 2023 | finance.yahoo.comShockwave Medical Provides Quarterly Earnings Release Dates for 2023January 4, 2023 | finance.yahoo.comTeleflex (TFX) OEM Arm Grows, Supply Issue PersistsJanuary 2, 2023 | finance.yahoo.comShockWave Medical's (NASDAQ:SWAV) investors will be pleased with their incredible 373% return over the last three yearsDecember 31, 2022 | finance.yahoo.comShockWave Medical, Inc. (NASDAQ:SWAV) Q3 2022 Earnings Call TranscriptDecember 29, 2022 | finance.yahoo.comNeogen (NEOG) Benefits From Advanced Portfolio, Global GrowthDecember 23, 2022 | finance.yahoo.comMcKesson (MCK) Announces Availability of FDA-Accepted DrugDecember 20, 2022 | finance.yahoo.comHere’s Why ShockWave Medical (SWAV) Outperformed in Q3See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive SWAV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ShockWave Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address SWAV Company Calendar Last Earnings11/07/2022Today2/01/2023Next Earnings (Confirmed)2/16/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SWAV CUSIPN/A CIK1642545 Webwww.shockwavemedical.com Phone(877) 775-4846FaxN/AEmployees657Year FoundedN/APrice Target and Rating Average Stock Price Forecast$244.44 High Stock Price Forecast$310.00 Low Stock Price Forecast$165.00 Forecasted Upside/Downside+30.1%Consensus RatingModerate Buy Rating Score (0-4)2.56 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)$2.33 Trailing P/E Ratio80.62 Forward P/E Ratio63.46 P/E GrowthN/ANet Income$-9,140,000.00 Net Margins20.48% Pretax Margin20.75% Return on Equity30.08% Return on Assets21.85% Debt Debt-to-Equity Ratio0.04 Current Ratio7.29 Quick Ratio6.02 Sales & Book Value Annual Sales$237.15 million Price / Sales28.63 Cash FlowN/A Price / Cash FlowN/A Book Value$6.85 per share Price / Book27.42Miscellaneous Outstanding Shares36,140,000Free Float34,732,000Market Cap$6.79 billion OptionableNot Optionable Beta1.04 Key ExecutivesDouglas Evan GodshallPresident, Chief Executive Officer & DirectorMike MaszyVice President-OperationsDaniel PuckettChief Financial Officer & SecretaryBeaux AlexanderVice President-Clinical AffairsW. Patrick StephensVice President-Research & DevelopmentKey CompetitorsInspire Medical SystemsNYSE:INSPGlobus MedicalNYSE:GMEDIntegra LifeSciencesNASDAQ:IARTPenumbraNYSE:PENHaemoneticsNYSE:HAEView All CompetitorsInsiders & InstitutionsKnights of Columbus Asset Advisors LLCSold 100 shares on 1/31/2023Ownership: 0.024%Summit Global InvestmentsSold 900 shares on 1/31/2023Ownership: 0.010%New York State Common Retirement FundBought 2,442 shares on 1/30/2023Ownership: 0.596%Sumitomo Mitsui Trust Holdings Inc.Bought 397 shares on 1/30/2023Ownership: 0.003%State of Michigan Retirement SystemBought 100 shares on 1/27/2023Ownership: 0.025%View All Insider TransactionsView All Institutional Transactions SWAV Stock - Frequently Asked Questions Should I buy or sell ShockWave Medical stock right now? 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ShockWave Medical in the last year. There are currently 1 sell rating, 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" SWAV shares. View SWAV analyst ratings or view top-rated stocks. What is ShockWave Medical's stock price forecast for 2023? 9 Wall Street analysts have issued 12-month price targets for ShockWave Medical's shares. Their SWAV share price forecasts range from $165.00 to $310.00. On average, they predict the company's share price to reach $244.44 in the next year. This suggests a possible upside of 30.1% from the stock's current price. View analysts price targets for SWAV or view top-rated stocks among Wall Street analysts. How have SWAV shares performed in 2023? ShockWave Medical's stock was trading at $205.61 at the beginning of the year. Since then, SWAV stock has decreased by 8.6% and is now trading at $187.93. View the best growth stocks for 2023 here. When is ShockWave Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, February 16th 2023. View our SWAV earnings forecast. How can I listen to ShockWave Medical's earnings call? ShockWave Medical will be holding an earnings conference call on Thursday, February 16th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link. How were ShockWave Medical's earnings last quarter? ShockWave Medical, Inc. (NASDAQ:SWAV) posted its quarterly earnings results on Monday, November, 7th. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.68 by $0.24. The company had revenue of $131.33 million for the quarter, compared to analysts' expectations of $125.85 million. ShockWave Medical had a trailing twelve-month return on equity of 30.08% and a net margin of 20.48%. What guidance has ShockWave Medical issued on next quarter's earnings? ShockWave Medical updated its earnings guidance on Wednesday, January, 18th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $143.00 million-$144.00 million, compared to the consensus revenue estimate of $141.50 million. What is Doug Godshall's approval rating as ShockWave Medical's CEO? 8 employees have rated ShockWave Medical Chief Executive Officer Doug Godshall on Glassdoor.com. Doug Godshall has an approval rating of 89% among the company's employees. What other stocks do shareholders of ShockWave Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other ShockWave Medical investors own include NVIDIA (NVDA), Walt Disney (DIS), Block (SQ), Trade Desk (TTD), Salesforce (CRM), Roku (ROKU), PayPal (PYPL), DexCom (DXCM), Alibaba Group (BABA) and Okta (OKTA). When did ShockWave Medical IPO? (SWAV) raised $75 million in an initial public offering (IPO) on Thursday, March 7th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers. What is ShockWave Medical's stock symbol? ShockWave Medical trades on the NASDAQ under the ticker symbol "SWAV." Who are ShockWave Medical's major shareholders? ShockWave Medical's stock is owned by many different institutional and retail investors. Top institutional shareholders include Baillie Gifford & Co. (0.96%), Allspring Global Investments Holdings LLC (0.90%), New York State Common Retirement Fund (0.60%), Strs Ohio (0.24%), Ziegler Capital Management LLC (0.13%) and New York State Teachers Retirement System (0.13%). Insiders that own company stock include Antoine Papiernik, Colin Cahill, Dan Puckett, Douglas Evan Godshall, Frank T Watkins, Frank T Watkins, Isaac Zacharias, Kurt F Gallo, Laura Francis, Maria Sainz, Sofinnova Capital Vii Fcpr and Trinh Phung. View institutional ownership trends. How do I buy shares of ShockWave Medical? Shares of SWAV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is ShockWave Medical's stock price today? One share of SWAV stock can currently be purchased for approximately $187.93. How much money does ShockWave Medical make? ShockWave Medical (NASDAQ:SWAV) has a market capitalization of $6.79 billion and generates $237.15 million in revenue each year. The company earns $-9,140,000.00 in net income (profit) each year or $2.33 on an earnings per share basis. How many employees does ShockWave Medical have? The company employs 657 workers across the globe. How can I contact ShockWave Medical? ShockWave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara CA, 95054. The official website for the company is www.shockwavemedical.com. The company can be reached via phone at (877) 775-4846 or via email at investors@shockwavemedical.com. This page (NASDAQ:SWAV) was last updated on 2/1/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.